Caption Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
163,544
+25,392
| +18% | +$215K | 0.02% | 192 |
|
|
2025
Q1 | $1.11M | Buy |
138,152
+111,482
| +418% | +$896K | 0.01% | 192 |
|
|
2024
Q4 | $239K | Buy |
+26,670
| New | +$239K | ﹤0.01% | 376 |
|
|
2024
Q3 | – | Sell |
-6,076
| Closed | -$34.7K | – | 470 |
|
|
2024
Q2 | $34.7K | Buy |
+6,076
| New | +$34.7K | ﹤0.01% | 358 |
|
|
2024
Q1 | – | Sell |
-114,200
| Closed | -$1.03M | – | 423 |
|
|
2023
Q4 | $1.03M | Buy |
114,200
+81,000
| +244% | +$728K | 0.01% | 153 |
|
|
2023
Q3 | $258K | Buy |
+33,200
| New | +$258K | ﹤0.01% | 284 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 383 |
|
|
2023
Q1 | – | Sell |
-21,900
| Closed | -$94.6K | – | 390 |
|
|
2022
Q4 | $94.6K | Sell |
21,900
-36,100
| -62% | -$156K | ﹤0.01% | 343 |
|
|
2022
Q3 | $436K | Buy |
58,000
+43,678
| +305% | +$328K | 0.01% | 241 |
|
|
2022
Q2 | $144K | Sell |
14,322
-31,967
| -69% | -$321K | ﹤0.01% | 376 |
|
|
2022
Q1 | $574K | Sell |
46,289
-27,166
| -37% | -$337K | 0.01% | 309 |
|
|
2021
Q4 | $1.68M | Buy |
+73,455
| New | +$1.68M | 0.02% | 188 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 550 |
|
|
2021
Q2 | – | Sell |
-19,500
| Closed | -$253K | – | 437 |
|
|
2021
Q1 | $253K | Sell |
19,500
-95,500
| -83% | -$1.24M | 0.01% | 274 |
|
|
2020
Q4 | $1.59M | Hold |
115,000
| – | – | 0.04% | 90 |
|
|
2020
Q3 | $1.69M | Sell |
115,000
-32,657
| -22% | -$481K | 0.04% | 82 |
|
|
2020
Q2 | $2.4M | Buy |
147,657
+113,457
| +332% | +$1.84M | 0.08% | 58 |
|
|
2020
Q1 | $497K | Buy |
34,200
+9,200
| +37% | +$134K | 0.03% | 141 |
|
|
2019
Q4 | $506K | Buy |
+25,000
| New | +$506K | 0.02% | 169 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 274 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 251 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 214 |
|